Long-term follow-up of the VenusP-Valve™ heart valve
Part of Heart & circulation, Lungs & breathing clinical trials.
This study checks on people who already received a VenusP-Valve™ heart valve. They will be followed for 6 to 10 years to see how the valve is working and if there are any long-term effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are already a participant in a VenusP-Valve™ study or have received the device.
- You (or your legal guardian) agree to join this long-term follow-up and sign a consent form.
- Your study doctor thinks it's safe and appropriate for you to continue.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This observational study follows people who need a pulmonary valve treatment, to see how the Venus P-Valve works in real-world care. It may help doctors understand which patients benefit and how outcomes change over time.
This study is a long-term follow-up for people who took part in the original VitaFlow heart valve trial at certain hospitals. It checks how well the replacement valve is working over time.
This study tests a new less-invasive heart valve (VenusP-Valve) for people whose own pulmonary valve is leaking severely. If you qualify, you could get the new valve without open-heart surgery.
This study tests a new type of heart valve (called Venus-Neo) to see if it is safe and works well for people who need their aortic valve replaced. If you qualify, you may receive this valve as part of the study and be followed over time to ensure it is working properly.
This study looks back at patients who were successfully treated with TricValve bicaval valve devices and then follows up with their outcomes. You might join if you (or your legal guardian) agree to be included.
This study tests an early, first-use version of a new pulmonary valve device for children whose own valve is not working well. It may help improve blood flow from the heart to the lungs and aims to learn how safe and effective the valve is over time.
Hear when a new Native Right Ventricle Outflow Tract(RVOT) Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.